慢性耐药焦点发作的负担:它可以预防吗?
Elinor Ben-Menachem1, Bettina Schmitz2, Reetta Kälviäinen3
1University of Gothenburg, Gothenburg, Sweden.
Epilepsy & behavior : E&B
|September 25, 2023
概括
许多患者在治疗中扎,面临着生活质量 (QoL) 差等风险. 本综述考察了影响患者 (PWE) 寿命的因素,以指导更好的护理策略.
科学领域:
- 神经学 神经学
- 生活质量研究 研究 生命质量研究
- 公共卫生 公共卫生
背景情况:
- 影响着相当一部分人口,尽管有治疗方法,但大量的人患有控制不良的发作.
- 耐治疗性带来风险,包括疾病进展,死亡率和发病率增加,心理健康问题以及生活质量 (QoL) 降低.
研究的目的:
- 在患者 (PWE) 中全面审查导致与健康相关的 QoL 损害的因素.
- 确定潜在的干预点和策略,以实现更全面的管理方法.
- 为医疗保健提供者和决策者提供有关改善PWE质量质量的信息.
主要方法:
- 系统性文献综述检查症中的QoL的研究.
- 分析影响与健康有关的QoL的与发作相关的和非发作相关的因素.
- 综合发现,提出整体护理策略.
主要成果:
- 确定了许多与发作相关的因素 (例如,发作频率,类型) 对PWE的QOL产生负面影响.
- 突出显著的非发作相关的贡献者降低了QOL,包括药物副作用,心理社会挑战和并发症.
- 演示了的严重程度和更广泛的生活领域之间影响整体幸福感的复杂相互作用.
结论:
- 整体方法对于改善PWE中与健康相关的QoL至关重要,不仅仅是控制.
- 干预措施应应对直接的影响和间接的后果,如精神困扰和社会因素.
- 需要基于证据的策略来提高QoL,并为全面的治疗政策提供信息.
更多相关视频
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.4K
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.7K
相关概念视频
01:24Arteries of the Lower Limbs
206
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
206
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
332
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
332
01:08Antiepileptic Drugs: Sodium Channel Blockers
639
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
639
01:14Antiepileptic Drugs: Glutamate Antagonists
407
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
407
01:20Antiepileptic Drugs: Potassium Channel Activators
203
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
203
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
446
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
446